Intelligence · Clinical Development
Pipeline search results
Programs matching “insulin” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 62 pipeline programs matching "insulin" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Insulin
United Therapeutics Europe Ltd
Acute Stroke
1 trial -
Insulin lispro
HALOZYME THERAPEUTICS, INC.
Diabetes Mellitus, Type II
1 trial -
Insulin lispro
HALOZYME THERAPEUTICS, INC.
Diabetes Mellitus, Type 1
2 trials -
ORMD-0801 (Insulin) capsule 8 mg BD
ORAMED PHARMACEUTICALS INC.
Diabetes Mellitus, Type 2
1 trial -
Oral Insulin
ORAMED PHARMACEUTICALS INC.
Non-Alcoholic Steatohepatitis (NASH)
1 trial -
Oshadi Icp
BRIGHT MINDS BIOSCIENCES INC.
Diabetes Mellitus, Insulin-Dependent, 1
1 trial -
Pro insulin peptide
Cardiff Oncology
Type 1 Diabetes
1 trial -
68Ga-NOTA-MAL-Cys39-exendin-4
The First People's Hospital of Lianyungang
Insulinoma
1 trial -
Insulin Lispro
HALOZYME THERAPEUTICS, INC.
Diabetes Mellitus
1 trial -
Insulin Peglispro
Eli Lilly and Company
Healthy Volunteers
1 trial -
Insulin aspart
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
Insulin degludec injection, RD15003
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Type 2 Diabetes
1 trial -
Investigating how NNC0487-0111 regulates insulin in adults with type 2 diabetes
NovoThirteen
Type 2 Diabetes
1 trial -
Oshadi Oral Insulin
BRIGHT MINDS BIOSCIENCES INC.
Diabetes
1 trial -
INSULIN GLARGINE
Sanofi-aventis Healthcare Pty Ltd
Diabetes mellitus II
1 trial -
INSULIN GLARGINE (HOE901)
Sanofi Pasteur
Diabetes Mellitus, Type 2
1 trial -
Insulin
The First People's Hospital of Lianyungang
Brain Injuries
1 trial -
Insulin
The First People's Hospital of Lianyungang
Acute Pancreatitis
1 trial -
Insulin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pancreatitis, Acute
1 trial -
Insulin Glargine
Eli Lilly and Company
Diabetes Mellitus, Type 2
1 trial -
Insulin Glargine
Sanofi Pasteur
Diabetes Mellitus, Type 2
2 trials -
Insulin glulisine
Sanofi Pasteur
Diabetes Mellitus, Type 1
1 trial -
Insulin lispro low mixture
Eli Lilly and Company
Type 2 Diabetes Mellitus
1 trial -
Pioglitazone and insulin
Takeda
Diabetes Mellitus
2 trials
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.